What Is a Rabbit Antibody?

Rabbit monoclonal antibodies (RabMAbs): A new generation of monoclonal antibodies used in scientific research, diagnosis and treatment. Rabbit monoclonal antibody technology improves the current difficult to replicate by replacing high-quality rabbit monoclonal antibodies with polyclonal or low-affinity mouse monoclonal antibodies. Diagnostic products.

Rabbit monoclonal antibody

Rabbit monoclonal antibodies (RabMAbs): a new generation of monoclonal antibodies for

In 1995, Dr. Katherine Knight successfully obtained in genetically modified rabbits at Loyola University of Chicago

The advent of rabbit monoclonal antibodies has brought many benefits. First, rabbit antisera often contain high-affinity antibodies that recognize a wider variety of epitopes than mouse antisera. Second, rabbit monoclonal antibodies are able to recognize many antigens that do not produce immunity in mice. Third, because the rabbit spleen is larger, more fusion experiments can be performed, making high-throughput screening of fused cells possible.

Rabbit monoclonal antibody antibody treatment

Rabbit monoclonal antibodies are used for treatment: By 2004, the market for therapeutic monoclonal antibodies is expected to be approximately $ 6.4 billion. Hundreds of therapeutic antibodies are expected to be developed for the treatment of various diseases in the next 10 years. Rabbit monoclonal antibody fusion cells and other proprietary technology from Epitomics provide the opportunity to release the energy of this new antibody and find new human monoclonal antibodies for medical needs.

Rabbit monoclonal antibody

Rabbit monoclonal antibodies as diagnostic products: For several years, it has been known that the rabbit immune system provides the best antibody reagents for diagnostic purposes. Many small compounds and peptides produce an effective immune response in rabbits. Therefore, rabbit polyclonal antibodies are used in a variety of drug screening and clinical diagnostic kits. Epitomics

Rabbit monoclonal antibody antibody drug

Rabbit monoclonal antibodies are a powerful tool for drug development: the complete sequencing of the human genome greatly affects the process of drug development. New drug development has shifted from traditional disease target selection to systematic search for disease targets using genomic information. Protein is closer to the cause of disease than DNA or RNA. Monoclonal antibodies are the most powerful tool available to detect protein specificity and sensitivity. In addition, monoclonal antibodies can specifically fight or enhance the function of proteins, making them a powerful tool for proteomics.

Rabbit monoclonal antibody antibody gene

Epitomics' technology will produce monoclonal antibodies for many gene products directly derived from DNA, peptides and proteins, screen for monoclonal antibodies that block function, and identify therapeutic antibody drugs. Epitomics will build a monoclonal antibody library for a large number of human-derived proteins. This will accelerate the development of new products for treatment, diagnosis and medical treatment, such as antibody chips.